Divis Labs, Dr. Reddy, Larsen and Toubro, Hindustan Unilever, and Nestle India gained an early edge…

Revenue from operations rose to Rs 5,534 crore in the period under review from Rs 5,011 crore i…

LiqMeds Group of companies specialises in the development, manufacturing and supply of oral liq…

Revenue from operations during the quarter under review stood at Rs 5,139.6 crore as against Rs…

As per sources, the last minutes negotiations are underway between the both companies, including ta…

Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…

Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…

In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…

India has the third highest number of billionaires in the world, behind the US and China. The count…

The Indian pharma sector has gone through many ups and downs in the last few years – like falling f…

India’s benchmark indices Sensex and Nifty50 are likely to open in the green on Thursday amid posit…

India’s equity markets are likely to open in the red on Wednesday amid negative cues in global mark…

The Association of Mutual Funds in India (AMFI) releases reclassification of largecap, midcap an…

The agreements allow these companies to manufacture remdesivir for distribution in 127 count…

Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…

As a result of an agreement with the drug maker announced earlier this week, the US Department …